Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series

CONCLUSIONS: Radiotherapy provides excellent disease control with acceptable toxicity among adult patients with craniopharyngioma. These data support the use of fractionated radiotherapy in adult patients with recurrent or gross residual disease after surgery. For inoperable patients or those with moderate or high surgical risk to neurologic and/or vascular structures, we advocate for limited surgical resection and postoperative radiotherapy to balance optimal tumor control with tumor- and treatment-related morbidity.PMID:35278157 | DOI:10.1007/s11060-022-03983-z

Source: Cancer Control - March 12, 2022 Category: Cancer & Oncology Authors: Michael S Rutenberg Adam L Holtzman Daniel J Indelicato Soon Huh Dinesh Rao Peter J Fiester Christopher G Morris Daryoush Tavanaiepour Robert J Amdur Source Type: research